Ascletis Pharma Market Cap

Ascletis Pharma has a market cap or net worth of 12.52 billion as of February 2, 2026. Its market cap has increased by 324.67% in one year.

Market Cap

12.52B

Enterprise Value

10.55B

Revenue

2.59M

Ranking

n/a

PE Ratio

n/a

Stock Price

13.02

Market Cap Chart

Since August 1, 2018, Ascletis Pharma's market cap has decreased from 15.69B to 12.52B, a decrease of -20.18%. That is a compound annual growth rate of -2.96%.

Market Cap History

Date	Market Cap	% Change
Jan 30, 2026	13.62B	21.16%
Dec 31, 2025	11.24B	287.10%
Dec 31, 2024	2.90B	90.74%
Dec 29, 2023	1.52B	-70.46%
Dec 30, 2022	5.15B	44.13%
Dec 31, 2021	3.58B	13.38%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Aug 1, 2018	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Ascentage Pharma Group International	17.70B
Keymed Biosciences	16.39B
Zai Lab	14.42B
Everest Medicines	13.76B
Guangzhou Innogen Pharmaceutical Group	13.61B
Nanjing Leads Biolabs	13.30B
Shanghai Haohai Biological Technology	10.71B
HBM Holdings	9.95B

Market Cap Rankings